Matrix-Bio, Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive global licensing and marketing agreement for metabolomic biomarkers ...
Nexture Bio has acquired Matrix F.T. Nexture Bio plans to make its expanded portfolio of high-performing adherent cell culture products available to a global range of customers and partners, including ...
SAN DIEGO, CA--(Marketwired - Oct 9, 2013) - Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) today announced that its Board of Directors has authorized a distribution on a pro rata basis as a dividend ...
SAN DIEGO, CA--(Marketwired - Jul 31, 2013) - Bio-Matrix Scientific Group Inc. (OTCQB: BMSN) provided an update today on its subsidiary, Regen BioPharma's Investigational New Drug (IND) application ...
SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN) and Its majority owned subsidiary Entest BioMedical Inc. (OTCBB: ENTB) announced today they have finalized a definitive ...
Bio-Matrix Scientific Group Inc. (OTCBB:BMSN) is a biotechnology company headquartered in San Diego, Ca. with a 15,000 sq. ft. facility that houses two secure cryogenic stem cell banks, three research ...